(Q68286993)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669831%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Measurement of aromatisation by a urine technique suitable for the evaluation of aromatase inhibitors in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669831%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Measurement of Aromatisation by a Urine Technique Suitable for the Evaluation of Aromatase Inhibitorsin Vivo (English)

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

25 October 2022

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

25 October 2022

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

25 October 2022

2

Lønning PE

1 reference

23 September 2019

S. Jacobs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669831

25 October 2022

B. Haynes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669831

25 October 2022

L. Griggs

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669831

25 October 2022

M. Dowsett

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1669831

25 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1669831

25 October 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669831%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

http://www.tandfonline.com/doi/pdf/10.3109/14756369109030396

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

Journal of Enzyme Inhibition and Medicinal Chemistry

25 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669831%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669831%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669831%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

315-325

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669831%20AND%20SRC:MED&resulttype=core&format=json

Source of Estrogen Production in Postmenopausal Women1

23 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489

25 October 2022

2

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

Aromatase inhibition by R 76713: experimental and clinical pharmacology

25 October 2022

3

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors

25 October 2022

4

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

The effect of the aromatase inhibitor, 4-(phenylthio)-4-androstene-3,17-dione, on dimethylbenz(A)anthracene-induced rat mammary tumors

25 October 2022

5

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

25 October 2022

6

46

4823

Goss P. E.

1986

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

A phase I trial of CGS 16949A. A new aromatase inhibitor

25 October 2022

7

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer

25 October 2022

9

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer

25 October 2022

10

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

Separation of urinary metabolites of radiolabelled estrogens in man by HPLC.

25 October 2022

11

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

The multicomponent analysis of estrogens in urine by ion exchange chromatography and GC-MS--I. Quantitation of estrogens after initial hydrolysis of conjugates

25 October 2022

13

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide

25 October 2022

14

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

Effect of aminoglutethimide on extraglandular metabolism of exogenous testosterone

25 October 2022

15

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

Metabolism of estrogens—natural and synthetic

25 October 2022

16

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

25 October 2022

17

1 reference

https://api.crossref.org/works/10.3109/14756369109030396

25 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1669831%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference